Resmed Inc. buy UBS Group AG
Start price
20.09.25
/
50%
€234.30
Target price
20.09.26
-
Performance (%)
-15.41%
Price
21.08.26
€198.20
Summary
This prediction is currently active. The price of Resmed Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -15.41%. This prediction currently runs until 20.09.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 2.165% | 2.165% |
| iShares Core DAX® | -1.283% | 4.209% |
| iShares Nasdaq 100 | -3.338% | -1.744% |
| iShares Nikkei 225® | -4.286% | -1.621% |
| iShares S&P 500 | -2.311% | -0.096% |
Comments by UBS_Group_AG for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Ratings data for RMD provided by MarketBeat